In this section
Dismiss Modal

Every cancer patient deserves a hospital that continues to search for the newest and most appropriate treatments.

Enrolling in clinical trials allows patients to potentially benefit from the latest breakthroughs, even before they become standard approaches. With more than 10% of GBMC cancer patients enrolled in these studies, we go well beyond most community hospitals in this area.

"These trials can potentially extend and save the lives of current patients, while preserving their quality of life and decreasing harmful side effects," Laura J. Morse Cucci, PhD, BSN, RN, Research Nurse Manager in the Sandra and Malcolm Berman Cancer Institute, said. "Our patients are contributing to the development of therapies that will save lives far into the future."

"I have added years to my life by being part of several trials," Ethel Zelenske, current patient and clinical trial participant, said. "Laura works closely with my doctors to make sure we are on track and always providing the right treatment."

We're more than just healthcare providers. We're your team. At GBMC, we face cancer, together.

Related Articles
Read article
Events and Awards
GBMC Earns CMS Five-Star Overall Hospital Quality Rating, Joining an Elite Group of U.S. Hospitals

The Centers for Medicare & Medicaid Services (CMS) recognized GBMC with a Five-Star Overall Hospital Qual...

Read article
Healthy Tips
Stay in the Game: Joint Health for Active Families

 Joint pain is one of the most common reasons people pull back from the activities they love. Dr. James J...

Read article
Healthy Tips
GBMC Rx: Stay ahead of knee pain this season

 As the warmer months bring more outdoor activity — hiking, running, pickleball, and more — knee pain...

Read article
Podcasts
In Full Bloom: Why Women’s Health Needs a Bigger Conversation

In the premiere episode of In Full Bloom: A Women’s Health Podcast, Joan Blomquist, MD, Chair of the Department of Gynecology at GBMC, and Mary Beth Marsden explore why women’s health deserves a broader, more open, and more evidence-based conversation.